Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Am J Med. 2012 May 3;125(7):709–716. doi: 10.1016/j.amjmed.2011.12.004

Table 6.

Outcomes of Patients with Venous Thromboembolism According to History of Diabetes

Diabetes (n = 476) No Diabetes (n = 2012) P Value
No complications, n (%) 309 (64.9) 1457 (72.4) .001
Recurrent pulmonary embolism,* n (%) 8 (1.7) 30 (1.5) .76
Recurrent deep vein thrombosis,* n (%) 71 (14.9) 216 (10.7) .01
Long-term major bleeding,* n (%) 78 (16.4) 235 (11.7) .01
In-hospital major bleeding, n (%) 27 (5.7) 76 (3.8) .07
Heparin-induced thrombocytopenia,* n (%) 6 (1.3) 19 (0.9) .70
In-hospital death, n (%) 30 (6.3) 83 (4.1) .05
Death within 30 days of venous thromboembolism diagnosis, n (%) 45 (9.9) 146 (7.5) .10
*

Long-term outcomes data encompassed a median follow-up period of 992 days.